Advertisement

Topics

Latest "OPKO Health Reference Laboratories" News Stories

16:32 EDT 22nd July 2018 | BioPortfolio

Here are the most relevant search results for "OPKO Health Reference Laboratories" found in our extensive news archives from over 250 global news sources.

More Information about OPKO Health Reference Laboratories on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about OPKO Health Reference Laboratories for you to read. Along with our medical data and news we also list OPKO Health Reference Laboratories Clinical Trials, which are updated daily. BioPortfolio also has a large database of OPKO Health Reference Laboratories Companies for you to search.

Showing "OPKO Health Reference Laboratories" News Articles 1–25 of 23,000+

Extremely Relevant

Opko Health (OPK) and Haemonetics (HAE) Financial Survey

Opko Health and Haemonetics are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Opko Health currently has a consensus price target of $12.10, suggesting a potential upside of 270.03%.


Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OPKO Health, Inc. - OPK

NEW YORK, NY / ACCESSWIRE / May 22, 2018 / Pomerantz LLP is investigating claims on behalf of investors of OPKO Health, Inc. ("OPKO" or the "Company") (NASDAQ: OPK). Such investors are advised to ...

OPKO Health’s Annual Report a Mixed Bag

OPKO Health’s fourth-quarter report highlighted positive activities in the face of a net loss of $213.9 million during the most recent quarter.


OPKO Health Reports First Quarter 2018 Financial Results

OPKO Health (NASDAQ:OPK) reports financial results and business highlights for the three months ended March 31, 2018. As quoted in the press release: “We are pleased to report steady sequential-quarter growth for RAYALDEE and 4Kscore, as well as improvement in our lab business from Q4 of last year,” said Phillip Frost, Chairman and Chief Executive Officer of … Continued The post OPKO H...

Active-Investors: Wired News - OPKO Health Announced Enrollment of First Patient in Phase-2b Trial of OPK88003 to Treat Type-2 Diabetes

Stock Monitor: Capricor Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 27, 2018 / Active-Investors.com has just released a free research report on OPKO Health, Inc. (NASDAQ: ...

Relevant

Merck enters agreement with HistoCyte Laboratories for distribution of reference products

Science and technology company, Merck, has entered into an agreement with HistoCyte Laboratories, for the distribution of its portfolio of cell line reference products for immunohistochemistry and in situ hybridisation.

OPKO Health: New Signs Of Chaos In Key Diagnostics Division

Opko Health: The Importance Of The 4kscore Test Study

OPKO Health's (OPK) CEO Phillip Frost on Q4 2017 Results - Earnings Call Transcript

BioSci Rounds Report: Elucidating Crispr Fundamentals Improvement And Opko Health Prospects

Opko Health to delist from TASE

The company, one of the largest on the Tel Aviv Stock Exchange, joins the exodus of dual-listed US biotech companies.

OPKO Health Is A High-Risk And High-Return Stock For 2018

OPK Up 36% In 5 Days, SLDB Sparkles, CERS Abuzz, ARWR Expects Data In Nov.

OPKO Health Inc. (OPK) has reported better-than-expected financial results for the first quarter ended March 31, 2018.

Get to Know Your Reference Genome (GRCh37 vs GRCh38)

Whether your experiment relies upon a reference-based genome assembly or mapping reads to a reference genome to identify variants, you need to choose a human reference genome assembly. But wait! You go to the FTP site of NCBI’s refseq and click on the Homo sapiens folder. There you are presented with two choices. Which one… The post Get to Know Your Reference Genome (GRCh37 vs GRCh38) appe...

Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology

Merck, a leading science and technology company, has announced that it has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, U.K., to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization....

PierianDx Announces TriCore Reference Laboratories as the Newest Customer to its Partner Sharing Network

PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that TriCore Reference Laboratories will utilize the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for genomic analytics, classification, interpretation and reporting. TriCore will join mor...

Critical Survey: Cardinal Health

Cardinal Health and Bio-Rad Laboratories are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership. Cardinal Health has higher revenue and earnings than Bio-Rad Laboratories.

Merck signs agreement with HistoCyte Laboratories

The science and technology company will be the exclusive multinational distributor of the company's portfolio of cell line reference products

Cell-based reference samples designed with specific differences in microRNA biomarkers

We demonstrate the feasibility of creating a pair of reference samples to be used as surrogates for clinical samples measured in either a research or clinical laboratory setting. The reference sample paradigm ...

Data Breach Reported at LabCorp, One of the Two Largest Reference Labs

LabCorp, one of the nation’s two largest reference labs in the U.S., is investigating a security breach that could have put health records of millions of patients at risk (see: LabCorp Investigates a Possible Data Breach). The company, in a filing with the Securities and Exchange Commission, says it detected...

Your Daily Pharma Scoop: Aratana Earnings, Vanda Offering, Opko 4kscore Shows Benefit

GeneNews Announces Collaboration with AIM Laboratories to Expand Test Utilization

GeneNews, through Innovative Diagnostic Laboratory ("IDL"), its wholly-owned subsidiary in Richmond, Virginia, operates a full service reference lab focused on early cancer risk stratification Read more...

Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses based on the strength of its dividends, analyst recommendations, institutional ownership, earnings, profitability, valuation and risk. IDEXX Laboratories has higher revenue and earnings than its rivals.

Esoteric Testing Market by Type Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing, Lab Type Independent Labs, Hospital Laboratories, Technology Mass Spectrometry, CLIA, ELISA, PCR Global Forecast to 2023 [Rep

Esoteric testing market projected to grow at a CAGR of 11.6%The esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%. Growth in this market is primarily driven by the increasing burden of chronic diseases majorly due to the rising geriatric population, rising prevalence of infectious diseases, rising demand for early disease dia...

Lot of 12 eppendorf pipette’s. reference, Research plus 1000 uL 100 uL and 25 uL

EUR 107,91 (9 Biedingen)Einddatum: zondag apr-22-2018 4:02:55 CESTNu bieden | Toevoegen aan volglijst Biotech365 : Lot of 12 eppendorf pipette’s. reference, Research plus 1000 uL 100 uL and 25 uL BioMarketplace You want to propose your products or a Biotech … Continue reading → Cet article Lot of 12 eppendorf pipette’s. reference, Research plus 1000 uL 100 uL and 25 uL...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks